skNAC is a Key Driver of Cardiomyocyte Integrity Against Pathological Cardiac Hypertrophy and Heart Failure

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

BACKGROUND

Myocardial hypertrophy caused by chronic pressure overload eventually leads to heart failure. Increased protein synthesis and sarcomere reorganization are crucial elements of cardiac remodeling under such conditions. The muscle-specific nascent polypeptide-associated complex alpha isoform (skNAC) is a protein essential for proper sarcomere organization during development. However, its role in hypertrophy and heart failure in adults remains unexplored. We investigated the function of skNAC in pressure overload-induced hypertrophy and heart failure.

METHODS

skNAC expression was assessed in neonatal rat ventricular cardiomyocytes (NRVMs) stimulated with phenylephrine, in human cardiac biopsies, and in mice subjected to transverse aortic constriction (TAC) or angiotensin II infusion. The impact of siRNA-mediated skNAC silencing was evaluated in NRVMs, while constitutive and inducible cardiomyocyte-specific skNAC knockout mouse models were generated to examine the long-term effects of skNAC deletion under both basal and TAC conditions. Immunofluorescence confocal microscopy and proximity ligation assay were used to assess skNAC localization and interactions, while electron microscopy was employed to analyze the consequences of skNAC deletion on cardiomyocyte ultrastructure.

RESULTS

skNAC expression was reduced in phenylephrine-treated NRVMs and in mice subjected to TAC or angiotensin II, due to decreased expression of the RNA-binding proteins Rbm24 and Rbm20, which regulate skNAC pre-mRNA splicing. Consistently, skNAC expression inversely correlated with cardiac hypertrophy and NT-proBNP levels in humans. Cardiomyocyte-specific skNAC deletion generated basal hypertrophy, severe systolic dysfunction, and premature death, which were further exacerbated by TAC surgery, leading to rapid dilated cardiomyopathy and lethality. skNAC strongly colocalized with ribosomes, and its deletion caused sarcomere disorganization and an autophagic response. Conversely, skNAC overexpression prevented phenylephrine-induced hypertrophy in NRVMs.

CONCLUSIONS

Our results demonstrate that skNAC is essential for preserving sarcomere integrity and cardiomyocyte homeostasis. Its downregulation drives pathological remodeling and heart failure, positioning skNAC as a promising therapeutic target.

Novelty and Significance

What is known?

  • Pathological cardiac hypertrophy and heart failure are associated with increased protein synthesis and sarcomere reorganization.

  • The muscle-specific nascent polypeptide-associated complex alpha isoform (skNAC) is required for sarcomere organization and stabilization of contractile proteins, and its deficiency causes defective myofibrillogenesis and cardiac structural abnormalities during development.

What new information does this article contribute?

  • This study identifies the muscle-specific nascent polypeptide-associated complex alpha isoform (skNAC) as a key regulator of cardiomyocyte integrity in adulthood, which is downregulated in pressure overload-induced cardiac hypertrophy and heart failure.

  • Cardiomyocyte-specific deletion of skNAC induces cardiac hypertrophy and heart failure, whereas its overexpression prevents the development of cardiomyocyte hypertrophy.

  • By interacting with ribosomes, skNAC contributes to cellular homeostasis and maintains myofibril structure.

Article activity feed